Identification of a novel A4GALT exon reveals the genetic basis of the P1/P2 histo-blood groups.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 20971946)

Published in Blood on October 22, 2010

Authors

Britt Thuresson1, Julia S Westman, Martin L Olsson

Author Affiliations

1: Department of Clinical Immunology and Transfusion Medicine, University and Regional Laboratories, Lund, Sweden.

Articles citing this

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang (2011) 1.19

Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88

Human genetic disorders of sphingolipid biosynthesis. J Inherit Metab Dis (2014) 0.81

The glycosphingolipid P₁ is an ovarian cancer-associated carbohydrate antigen involved in migration. Br J Cancer (2014) 0.81

An innovative method to identify autoantigens expressed on the endothelial cell surface: serological identification system for autoantigens using a retroviral vector and flow cytometry (SARF). Clin Dev Immunol (2013) 0.80

A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome. J Biol Chem (2012) 0.80

Comparative genomics reveals molecular features unique to the songbird lineage. BMC Genomics (2014) 0.79

Comprehensive red blood cell and platelet antigen prediction from whole genome sequencing: proof of principle. Transfusion (2015) 0.78

Identification of the Molecular and Genetic Basis of PX2, a Glycosphingolipid Blood Group Antigen Lacking on Globoside-deficient Erythrocytes. J Biol Chem (2015) 0.77

Altered (neo-) lacto series glycolipid biosynthesis impairs α2-6 sialylation on N-glycoproteins in ovarian cancer cells. Sci Rep (2017) 0.75

Evaluation of an amino acid residue critical for the specificity and activity of human Gb3/CD77 synthase. Glycoconj J (2016) 0.75

Articles by these authors

Bacterial glycosidases for the production of universal red blood cells. Nat Biotechnol (2007) 2.41

The human P(k) histo-blood group antigen provides protection against HIV-1 infection. Blood (2009) 1.55

Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol (2012) 1.46

Additional molecular bases of the clinically important p blood group phenotype. Transfusion (2003) 1.43

The Bloodgen Project of the European Union, 2003-2009. Transfus Med Hemother (2009) 1.36

ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ Res (2004) 1.32

The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion (2007) 1.24

Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn (2007) 1.15

Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease. J Infect Dis (2004) 1.14

The cis-AB blood group phenotype: fundamental lessons in glycobiology. Transfus Med Rev (2006) 1.12

Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev (2010) 1.11

Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood (2002) 1.09

Identification of a GH110 subfamily of alpha 1,3-galactosidases: novel enzymes for removal of the alpha 3Gal xenotransplantation antigen. J Biol Chem (2008) 1.07

The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis. Blood (2010) 1.05

Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, and novel therapeutic opportunities for α(1)-microglobulin. Antioxid Redox Signal (2012) 1.04

Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat Genet (2013) 1.02

An extensive polymerase chain reaction-allele-specific polymorphism strategy for clinical ABO blood group genotyping that avoids potential errors caused by null, subgroup, and hybrid alleles. Transfusion (2007) 1.00

Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia. Free Radic Biol Med (2009) 0.99

Platelet concentrate increases bone ingrowth into porous hydroxyapatite. Orthopedics (2002) 0.98

Many genetically defined ABO subgroups exhibit characteristic flow cytometric patterns. Transfusion (2009) 0.96

Identification of six new alleles at the FUT1 and FUT2 loci in ethnically diverse individuals with Bombay and Para-Bombay phenotypes. Transfusion (2006) 0.93

Weak A phenotypes associated with novel ABO alleles carrying the A2-related 1061C deletion and various missense substitutions. Transfusion (2010) 0.92

Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system. Blood (2012) 0.91

ABO exon and intron analysis in individuals with the AweakB phenotype reveals a novel O1v-A2 hybrid allele that causes four missense mutations in the A transferase. BMC Genet (2003) 0.89

Erythroid urea transporter deficiency due to novel JKnull alleles. Transfusion (2007) 0.88

A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycoconj J (2010) 0.86

ABO blood groups influence macrophage-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes. PLoS Pathog (2012) 0.86

Genetic basis of the K(0) phenotype in the Swedish population. Transfusion (2005) 0.85

Blood grouping discrepancies between ABO genotype and phenotype caused by O alleles. Curr Opin Hematol (2008) 0.82

Clonogenicity, gene expression and phenotype during neutrophil versus erythroid differentiation of cytokine-stimulated CD34+ human marrow cells in vitro. Br J Haematol (2004) 0.82

Structural effects of naturally occurring human blood group B galactosyltransferase mutations adjacent to the DXD motif. J Biol Chem (2007) 0.82

A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome. Mol Immunol (2009) 0.82

Will Genotyping Replace Serology in Future Routine Blood Grouping? - Opinion 4: Personalized versus Universal Blood Transfusions - Combining the Efforts. Transfus Med Hemother (2009) 0.81

Expression of a novel missense mutation found in the A4GALT gene of Amish individuals with the p phenotype. Transfusion (2007) 0.81

Molecular basis of the globoside-deficient P(k) blood group phenotype. Identification of four inactivating mutations in the UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene. J Biol Chem (2002) 0.81

Two previously proposed P1/P2-differentiating and nine novel polymorphisms at the A4GALT (Pk) locus do not correlate with the presence of the P1 blood group antigen. BMC Genet (2005) 0.81

Novel alleles at the JK blood group locus explain the absence of the erythrocyte urea transporter in European families. Br J Haematol (2002) 0.80

Characterization of Jk(a+(weak)): a new blood group phenotype associated with an altered JK*01 allele. Transfusion (2011) 0.79

Genetic basis of blood group diversity. Br J Haematol (2004) 0.79

The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes. Clin Dev Immunol (2011) 0.79

Application of DNA analysis to the quality assurance of reagent red blood cells. Transfusion (2007) 0.79

ABO transcript levels in peripheral blood and erythropoietic culture show different allele-related patterns independent of the CBF/NF-Y enhancer motif and multiple novel allele-specific variations in the 5'- and 3'-noncoding regions. Transfusion (2007) 0.78

Quantitative and qualitative evaluation of plasma and urine alpha1-microglobulin in healthy donors and patients with different haemolytic disorders and haemochromatosis. Clin Chim Acta (2007) 0.78

Allelic variants of PRDM9 associated with high hyperdiploid childhood acute lymphoblastic leukaemia. Br J Haematol (2014) 0.77

P1/P2 genotyping of known and novel null alleles in the P1PK and GLOB histo-blood group systems. Transfusion (2013) 0.77

Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferase. Transfusion (2007) 0.76

Flow cytometry evaluation of red blood cells mimicking naturally occurring ABO subgroups after modification with variable amounts of function-spacer-lipid A and B constructs. Transfusion (2011) 0.75

An age-dependent ABO discrepancy between mother and baby reveals a novel A(weak) allele. Transfusion (2014) 0.75

Large deletions involving the regulatory upstream regions of A4GALT give rise to principally novel P1PK-null alleles. Transfusion (2014) 0.75

Fondaparinux or enoxaparin: a comparative study of postoperative bleeding in coronary artery bypass grafting surgery. Scand Cardiovasc J (2010) 0.75

[A rare blood group: p phenotype]. Medicina (B Aires) (2009) 0.75

Transfusion medicine: a target on the move. Curr Opin Hematol (2009) 0.75

New and unusual O alleles at the ABO locus are implicated in unexpected blood group phenotypes. Transfusion (2005) 0.75

Rabbit red blood cell stroma bind immunoglobulin M antibodies regardless of blood group specificity. Transfusion (2006) 0.75

Investigation into A antigen expression on O2 heterozygous group O-labeled red blood cell units. Transfusion (2008) 0.75

Two cases of hemolytic uremic syndrome caused by Streptococcus pneumoniae serotype 3, one being a vaccine failure. Scand J Infect Dis (2012) 0.75